edoc

Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland

Schur, Nadine and Gudala, Kapil and Vudumula, Umakanth and Vadapelle, Sreelatha and Bhadhuri, Arjun and Casanova, Alain and Adlard, Nicholas and Schwenkglenks, Matthias. (2021) Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland. PharmacoEconomics, 39 (5). pp. 563-577.

[img] PDF - Published Version
Available under License CC BY-NC (Attribution-NonCommercial).

1933Kb

Official URL: https://edoc.unibas.ch/82867/

Downloads: Statistics Overview


Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Schur, Nadine and Bhadhuri, Arjun and Schwenkglenks, Matthias
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Adis International
ISSN:1170-7690
e-ISSN:1179-2027
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Identification Number:
edoc DOI:
Last Modified:30 Apr 2021 10:27
Deposited On:30 Apr 2021 10:27

Repository Staff Only: item control page